Doctors Issue Warning on Potential Birth Defects from Weight-Loss Jabs for Women Trying to Conceive

Doctors have issued a warning about the potential risks of weight-loss jabs for women hoping to become pregnant. The key ingredient in medications like Wegovy and Ozempic, semaglutide, has been linked to unexpected pregnancies in some women. This has led to concerns about the possibility of birth defects if these medications are used by women trying to conceive.

British scientists have advised women taking these medications to use contraception and stop taking them at least two months before attempting to get pregnant. The jabs work by mimicking a hormone that suppresses appetite and helps people feel full faster, but they may have unintended consequences for women trying to conceive.

Experts believe that the increase in fertility seen in some women taking these medications could be due to weight loss helping to regulate ovulation and menstruation. However, side effects like nausea and vomiting could also interfere with the effectiveness of contraceptive pills, leading to unexpected pregnancies.

Specialists have cautioned against using these weight-loss jabs as a method to boost fertility, citing potential harm based on animal studies. Non-pharmaceutical weight loss methods are recommended before pregnancy, and further research is needed to determine the safety and effectiveness of these medications for women trying to conceive.

This alert about the risks of weight-loss jabs for women hoping to become pregnant highlights the importance of understanding the potential consequences of these medications on fertility and pregnancy. It serves as a reminder for women to consult with their healthcare providers before starting any weight-loss treatment, especially if they are planning to conceive.